Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Cited by (1,001)

Items 301–400 of 1,001

1. A chitosan-mediated inhalable nanovaccine against SARS-CoV-2
   Shao‐Hua Zhuo, Jun Wu, Lang Zhao, Wenhao Li, Yufen Zhao, Yanmei Li · 2022 · Nano Research
2. Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
   Laurent Rénia, Yun Shan Goh, Angéline Rouers, Nina Le Bert, Wan Ni Chia, Jean‐Marc Chavatte, Siew‐Wai Fong, Zi Wei Chang, Nicole Ziyi Zhuo, Matthew Zirui Tay et al. · 2022 · Nature Communications
3. Pattern of circulating SARS‐CoV‐2‐specific antibody‐secreting and memory B‐cell generation in patients with acute COVID‐19
   Maria G. Byazrova, Gaukhar M. Yusubalieva, Anna A. Spiridonova, Grigory Aleksandrovich Efimov, Dmitriy V. Mazurov, Konstantin O. Baranov, Vladimir P. Baklaushev, Alexander V. Filatov · 2021 · Clinical & Translational Immunology
4. SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19
   Vivian Glück, Sonja Grobecker, Leonid Tydykov, Bernd Salzberger, Thomas Glück, Tanja Weidlich, Manuela Bertok, Christine Gottwald, Jürgen J. Wenzel, André Gessner et al. · 2021 · Infection
5. Interferon system deficiencies exacerbating severe pandemic virus infections
   Silke Stertz, Benjamin G. Hale · 2021 · Trends in Microbiology
6. Emergence and outcomes of the SARS-CoV-2 ‘Marseille-4’ variant
   Pierre‐Edouard Fournier, Philippe Colson, Anthony Levasseur, Christian Albert Devaux, Philippe Gautret, Marielle Bedotto, Jérémy Delerce, Ludivine Bréchard, Lucile Pinault, Jean‐Christophe Lagier et al. · 2021 · International Journal of Infectious Diseases
7. The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2
   Amar Sarkar, Siobhán Harty, Andrew H. Moeller, Sabra L. Klein, Susan E. Erdman, Karl John Friston, Rachel N. Carmody · 2021 · Trends in Molecular Medicine
8. Understanding “Hybrid Immunity”: Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines
   Nusrat J Epsi, Stephanie A Richard, David A Lindholm, Katrin Mende, Anuradha Ganesan, Nikhil Huprikar, Tahaniyat Lalani, Anthony C Fries, Ryan C. Maves, Rhonda E Colombo et al. · 2022 · Clinical Infectious Diseases
9. Resolving SARS-CoV-2 CD4+ T cell specificity via reverse epitope discovery
   Mikhail V. Pogorelyy, Elisa Rosati, Anastasia A. Minervina, Robert C. Mettelman, Alexander Scheffold, André Franke, Petra Bächer, Paul Glyndwr Thomas · 2022 · Cell Reports Medicine
10. A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection
    Iris N. Pardieck, Tetje Cornelia van der Sluis, Esmé T.I. van der Gracht, Dominique M. B. Veerkamp, Felix M. Behr, Suzanne van Duikeren, Guillaume Beyrend, Jasper Rip, Reza Nadafi, Elham Beyranvand Nejad et al. · 2022 · Nature Communications
11. Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19
    Eric Yuk Fai Wan, Vincent Ka Chun Yan, Anna Hoi Ying Mok, Boyuan Wang, Wanchun Xu, Franco Wing Tak Cheng, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, Xue Li, Carlos King Ho Wong et al. · 2023 · Annals of Internal Medicine
12. Correlates of Vaccine-Induced Protection against SARS-CoV-2
    Till Koch, Sibylle C. Mellinghoff, Parichehr Shamsrizi, Marylyn M. Addo, Christine Dahlke · 2021 · Vaccines
13. Aging and Options to Halt Declining Immunity to Virus Infections
    Miguel Ángel Palacios-Pedrero, Albert D. M. E. Osterhaus, Tanja Becker, Husni Elbahesh, Guus F. Rimmelzwaan, Giulietta Saletti · 2021 · Frontiers in Immunology
14. Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19
    Annamaria Paolini, Rebecca Borella, Sara De Biasi, Anita Neroni, Marco Mattioli, Domenico Lo Tartaro, Cecilia Simonini, Laura Franceschini, Gerolamo Cicco, Anna Maria Piparo et al. · 2021 · Cells
15. SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19
    Paul Chen, Niklas Bobrovitz, Zahra Premji, Marion Koopmans, David N. Fisman, Frank Gu · 2021 · eLife
16. Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine
    Christopher L. D. McMillan, Jovin J. Y. Choo, Adi Idris, Aroon Supramaniam, Naphak Modhiran, Alberto Anastacio Amarilla, Ariel Isaacs, Stacey T. M. Cheung, Benjamin Liang, Helle Bielefeldt‐Ohmann et al. · 2021 · Science Advances
17. Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and university staff
    Yoshifumi Uwamino, Toshinobu Kurafuji, Yasunori Sato, Yukari Tomita, Ayako Shibata, Akiko Tanabe, Yoko Yatabe, Masayo Noguchi, Tomoko Arai, Akemi Ohno et al. · 2022 · Vaccine
18. Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
    Tamàs Fülöp, Anis Larbi, Graham Pawelec, Alan Arthur Cohen, Guillaume Provost, Abdelouahed Khalil, Guy Lacombe, Serafim Rodrigues, Mathieu Desroches, Katsuiku Hirokawa et al. · 2022 · Vaccines
19. Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors
    Alison Tarke, Marina Potestà, Stefania Varchetta, Daniela Fenoglio, Marco Iannetta, Loredana Sarmati, Dalila Mele, Chiara Dentone, Matteo Bassetti, Carla Montesano et al. · 2022 · International Journal of Molecular Sciences
20. COVID‐19 immunopathology: From acute diseases to chronic sequelae
    Mohd Arish, Wei Guo Qian, Harish Narasimhan, Jie Sun · 2022 · Journal of Medical Virology
21. Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity
    Lisa Loksø Dietz, Anna Karina Juhl, Ole Schmeltz Søgaard, Joanne Reekie, Henrik Nielsen, Işık Somuncu Johansen, Thomas Benfield, Lothar Wiese, Nina Breinholt Stærke, Tomas Østergaard Jensen et al. · 2023 · Communications Medicine
22. Molecular mimicry in multisystem inflammatory syndrome in children
    Aaron Bodansky, Robert C. Mettelman, Joseph J. Sabatino, Sara E. Vazquez, Janet S. Chou, Tanya Novak, Kristin L. Moffitt, Haleigh S. Miller, Andrew F. Kung, Elze Rackaityte et al. · 2024 · Nature
23. Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health
    Liam Townsend, Adam H. Dyer, Aifric Naughton, Rachel Kiersey, Dean Holden, Mary Gardiner, Joanne Dowds, Kate O’Brien, Ciarán Bannan, Parthiban Nadarajan et al. · 2021 · Frontiers in Immunology
24. One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms
    Andreas Rank, Athanasia Tzortzini, Elisabeth Kling, Christoph Schmid, Rainer Claus, Eva Loell, Roswitha Burger, Christoph Römmele, Christine Dhillon, Katharina Müller et al. · 2021 · Journal of Clinical Medicine
25. The way of SARS-CoV-2 vaccine development: success and challenges
    Yetian Dong, Tong Dai, Bin Wang, Lei Zhang, Linghui Zeng, Jun Huang, Haiyan Yan, Long Zhang, Fangfang Zhou · 2021 · Signal Transduction and Targeted Therapy
26. The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis
    Tawanda Chivese, Joshua T. Matizanadzo, Omran A. H. Musa, George Hindy, Luis Furuya‐Kanamori, Nazmul Islam, Rafal Al-Shebly, Rana Shalaby, Mohammad Habibullah, Talal A. Al-Marwani et al. · 2022 · Pathogens and Global Health
27. Virus-Like Particle-Templated Silica-Adjuvanted Nanovaccines with Enhanced Humoral and Cellular Immunity
    Min Li, Zhihui Liang, Chen Chen, Ge Yu, Zhiying Yao, Yiyang Guo, Lei Zhang, Hang Bao, Duo Fu, Xuecheng Yang et al. · 2022 · ACS Nano
28. Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study
    Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, Anna Hoi Ying Mok, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, Xue Li, Carlos King Ho Wong, Philip Hei Li, Tiantian Ma et al. · 2022 · Emerging Microbes & Infections
29. Commercialized kits to assess T-cell responses against SARS-CoV-2 S peptides. A pilot study in health care workers
    Mónica Martínez‐Gallo, Juliana Esperalba, Ricardo Pujol‐Borrell, Víctor Sandá, Iria Arrese-Muñoz, Candela Fernández‐Naval, Andrés Antón, Victória Cardona, Moisés Labrador‐Horrillo, Tomàs Pumarola et al. · 2021 · Medicina Clínica
30. TLRs in COVID-19: How they drive immunopathology and the rationale for modulation
    Frances Linzee Mabrey, Eric D. Morrell, Mark M. Wurfel · 2021 · Innate Immunity
31. High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform
    Peter M. Bruno, Richard T. Timms, Nouran S. Abdelfattah, Yumei Leng, Felipe Lelis, Duane R. Wesemann, Xu G. Yu, Stephen Joseph Elledge · 2023 · Nature Biotechnology
32. Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection
    Ting Xue, Xiaomei Kong, Liang Ma · 2023 · Journal of Fungi
33. T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19
    Reza Zonozi, Lucy C. Walters, Aaron Shulkin, Vivek Naranbhai, Pravarut Nithagon, Gabriel Sauvage, Clarety Kaeske, Katherine M. Cosgrove, Anusha Nathan, Rhoda Tano-Menka et al. · 2023 · Science Translational Medicine
34. High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells
    Jennifer Chen, Ryan Dz-Wei Chow, Eric Song, Tianyang Mao, Benjamin Israelow, Kathy Kamath, Joel D. Bozekowski, Winston A. Haynes, Renata B. Filler, Bridget L. Menasché et al. · 2022 · Science Immunology
35. Anti-SARS-CoV-2 Spike Protein RBD Antibody Levels After Receiving a Second Dose of ChAdOx1 nCov-19 (AZD1222) Vaccine in Healthcare Workers: Lack of Association With Age, Sex, Obesity, and Adverse Reactions
    Sang Won Lee, Ji‐Yong Moon, Sun-Kyung Lee, Hyun Jung Lee, SeolHwa Moon, Sung Jun Chung, Yoomi Yeo, Tai Sun Park, Dong Won Park, Tae‐Hyung Kim et al. · 2021 · Frontiers in Immunology
36. Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
    Lilit Grigoryan, Audrey W. Q. Lee, Alexandra C. Walls, Lilin Lai, Benjamin D Franco, Prabhu S. Arunachalam, Yupeng Feng, Wei Luo, Abigail Vanderheiden, Katharine A. Floyd et al. · 2022 · npj Vaccines
37. Protective neutralizing epitopes in SARS‐CoV‐2
    Hejun Liu, Ian A. Wilson · 2022 · Immunological Reviews
38. Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape
    André E. Nel, Jeff F. Miller · 2021 · ACS Nano
39. Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients
    Ling Ni, Meng‐Li Cheng, Hui Zhao, Yu Feng, Jingyuan Liu, Fang Ye, Qing Ye, Gengzhen Zhu, Xiaoli Li, Pengzhi Wang et al. · 2021 · Frontiers in Immunology
40. Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
    Hassan Alkharaan, Shaghayegh Bayati, Cecilia Hellström, Soo Aleman, Annika Olsson, Karin Lindahl, Gordana Bogdanović, Katie Healy, Georgios Tsilingaridis, Patricia Palma et al. · 2021 · The Journal of Infectious Diseases
41. Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients
    Louise Benning, Christian P. Morath, Marie Bartenschlager, Heeyoung Kim, Marvin Reineke, Jörg Beimler, Mirabel Buylaert, Christian Nußhag, Florian Kälble, Paula Reichel et al. · 2022 · American Journal of Transplantation
42. Insufficient epitope-specific T cell clones are responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in older adults
    Chanchan Xiao, Zhiyao Ren, Bei Zhang, Lipeng Mao, Guodong Zhu, Lijuan Gao, Jun Su, Jiezhou Ye, Ze Long, Yue Zhu et al. · 2023 · Nature Aging
43. Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies
    Nicola Cotugno, Alessandra Ruggiero, Francesco Bonfante, Maria Raffaella Petrara, Sonia Zicari, Giuseppe Rubens Pascucci, Paola Zangari, Maria Antonietta De Ioris, Veronica Santilli, Emma Concetta Manno et al. · 2021 · Cell Reports
44. Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination
    Alberto Cagigi, Meng Yu, Björn Österberg, Julia Svensson, Sara Falck‐Jones, Sindhu Vangeti, Eric Åhlberg, Lida Azizmohammadi, Anna Warnqvist, Ryan Falck‐Jones et al. · 2021 · JCI Insight
45. SARS-CoV-2–specific B- and T-cell immunity in a population-based study of young Swedish adults
    Sophia Björkander, Likun Du, Fanglei Zuo, Sandra Ekström, Yating Wang, Hui Wan, Natalia Sherina, Lisanne Schoutens, Juni Andréll, Niklas Andersson et al. · 2021 · Journal of Allergy and Clinical Immunology
46. Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status
    Esther Dawen Yu, Eric W. Wang, Emily Garrigan, Benjamin Goodwin, Aaron Sutherland, Alison Tarke, James Chang, Rosa Isela Gálvez, José Mateus, Sydney I. Ramirez et al. · 2022 · Cell Host & Microbe
47. Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    Sudeb C. Dalai, Jennifer N. Dines, Thomas M. Snyder, Rachel Gittelman, Tera Newman-Eerkes, Pashmi Vaney, Sally Howard, Kipp Akers, Lynell R. Skewis, Anthony J. Monteforte et al. · 2022 · Clinical Infectious Diseases
48. Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay
    Gustavo Alberto Echeverría, Angel Gustavo Guevara, Joséfina Coloma, Alison Mera Ruiz, María Mercedes Vasquez, Eduardo Tejera, Jacobus Henri de Waard · 2021 · International Journal of Infectious Diseases
49. System-wide transcriptome damage and tissue identity loss in COVID-19 patients
    Jiwoon Park, Jonathan Foox, TYLER D. HETHER, David Danko, Sarah E. Warren, Youngmi Kim, Jason Reeves, Daniel Butler, Christopher Mozsary, Joel A. Rosiene et al. · 2022 · Cell Reports Medicine
50. Expert review on global real-world vaccine effectiveness against SARS-CoV-2
    Sunate Chuenkitmongkol, Rontgene Solante, Erlina Burhan, Suwat Chariyalertsak, Nan‐Chang Chiu, Do Van Dung, Masliyana Husin, Kao‐Pin Hwang, Sasisopin Kiertiburanakul, Prasad Suryakant Kulkarni et al. · 2022 · Expert Review of Vaccines
51. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
    Esther Moga, Elionor Lynton‐Pons, Peré Domingo · 2022 · Frontiers in Immunology
52. Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens
    Shona C. Moore, Barbara Kronsteiner, Stéphanie Longet, Sandra Adele, Alexandra S. Deeks, Chang Liu, Wanwisa Dejnirattisai, Laura Silva-Reyes, Naomi Meardon, Sian Elizabeth Faustini et al. · 2023 · Med
53. Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge
    Ting Y. Wong, Katherine S. Lee, Brynnan P. Russ, Alexander M. Horspool, Jason H. Kang, Michael T. Winters, M. Allison Wolf, Nathaniel A. Rader, Olivia A. Miller, Morgane Shiflett et al. · 2022 · npj Vaccines
54. Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach
    Alessandra D’Abramo, Serena Vita, Gaetano Maffongelli, Andrea Mariano, Chiara Agrati, Concetta Castilletti, Delia Goletti, Giuseppe Ippolito, Emanuele Nicastri · 2021 · International Journal of Infectious Diseases
55. Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19
    Rohan Ameratunga, Hilary J Longhurst, Richard Henderson Steele, Klaus Lehnert, Euphemia Yee Leung, Anna E. S. Brooks, See‐Tarn Woon · 2021 · The Journal of Allergy and Clinical Immunology In Practice
56. Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19
    Janna Heide, Sophia Schulte, Matin Kohsar, Thomas Theo Brehm, Marissa Herrmann, Hendrik Karsten, Matthias Marget, Sven Peine, Alexandra M. Johansson, Alessandro Sette et al. · 2021 · PLoS Pathogens
57. NK cell receptor and ligand composition influences the clearance of SARS-CoV-2
    Wan-Chen Hsieh, En‐Yu Lai, Yuting Liu, Yi‐Fu Wang, Yi-Shiuan Tzeng, Lu Cui, Yun‐Ju Lai, Hsiang‐Chi Huang, Jia‐Hsin Huang, Hung Chih Ni et al. · 2021 · Journal of Clinical Investigation
58. Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape
    Manojit Bhattacharya, Srijan Chatterjee, Ashish Ranjan Sharma, Sang‐Soo Lee, Chiranjib Chakraborty · 2022 · Folia Microbiologica
59. Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection
    Dawei Cui, Yuan Tang, Qi Jiang, Daixi Jiang, Yun Zhang, Yan Lv, Dandan Xu, Jian Wu, Jue Xie, Chengping Wen et al. · 2021 · Frontiers in Immunology
60. T‐cell recovery and evidence of persistent immune activation 12 months after severe COVID ‐19
    Patrick Taeschler, Sarah Adamo, Yun Deng, Carlo Cervia, Yves Zurbuchen, Stéphane Chevrier, Miro E. Raeber, Sara Hasler, Esther Bächli, Alain Rudiger et al. · 2022 · Allergy
61. Impaired Humoral Immunity Is Associated With Prolonged COVID-19 Despite Robust CD8 T-Cell Responses
    Olga Lyudovyk, Justin Y. Kim, David Augustus Qualls, Madeline A. Hwee, Ya-Hui Lin, Sawsan R. Boutemine, Yuval Elhanati, Alexander Solovyov, Melanie Douglas, Eunise Chen et al. · 2022 · Cancer Cell
62. T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenance
    Xin Gao, Kaiming Luo, Diya Wang, Yunbo Wei, Yin Yao, Jun Deng, Yang Yang, Qunxiong Zeng, Xiaoru Dong, Le Xiong et al. · 2023 · eLife
63. Emergence of immunosuppressive LOX-1+ PMN-MDSC in septic shock and severe COVID-19 patients with acute respiratory distress syndrome
    Rémy Coudereau, Louis Waeckel, Martin Cour, Thomas Rimmele, Rémi Pescarmona, Astrid Fabri, Laurent Jallades, Hodane Yonis, Morgane Gossez, Anne‐Claire Lukaszewicz et al. · 2021 · Journal of Leukocyte Biology
64. Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview
    Igor Vladimirovich Kudryavtsev, Artem Rubinstein, А. С. Головкин, Olga Kalinina, Kirill Vasilyev, Руденко Лариса Георгиевна, Исакова-Сивак Ирина Николаевна · 2022 · Viruses
65. Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection
    Karolin I. Wagner, Laura Marlene Mateyka, Sebastian Jarosch, Vincent Grass, Simone Weber, Kilian Schober, Monika Hammel, Teresa Burrell, Behnam Naderi Kalali, Holger Poppert et al. · 2021 · Cell Reports
66. Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses
    Harikrishnan Balachandran, Chansavath Phetsouphanh, David Agapiou, Anurag Adhikari, Chaturaka Rodrigo, Mohamed Hammoud, Lok Bahadur Shrestha, Elizabeth Keoshkerian, Money Gupta, Stuart Grant Turville et al. · 2022 · Cell Reports
67. Machine learning identifies T cell receptor repertoire signatures associated with COVID-19 severity
    Jonathan Joon-Young Park, Kyoung A. Viola Lee, Stanley Z. Lam, Katherine S. Moon, Zhenhao Fang, Sidi Chen · 2023 · Communications Biology
68. The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses
    Ricardo da Silva Antunes, Daniela Weiskopf, John Sidney, Paul Rubiro, Bjoern Peters, Cecilia S. Lindestam Arlehamn, Alba Grifoni, Alessandro Sette · 2023 · Current Protocols
69. Testing Fractional doses of COVID-19 Vaccines
    Witold Więcek, Amrita Ahuja, Esha Chaudhuri, Michael R. Kremer, Alexandre Simoes Gomes, Christopher M. Snyder, Alexander T. Tabarrok, Brandon Joel Tan · 2021 · Proceedings of the National Academy of Sciences
70. Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine
    Alexandra Atalis, Mark Cole Keenum, Bhawana Pandey, Alexander Beach, Pallab Pradhan, Casey E. Vantucci, Laura O’Farrell, Richard Noel, Ritika Jain, Justin Hosten et al. · 2022 · Journal of Controlled Release
71. Decline in neutralising antibody responses, but sustained T‐cell immunity, in COVID‐19 patients at 7 months post‐infection
    Jun Chen, Xiaomin Liu, Xinyu Zhang, Yixiao Lin, Danping Liu, Jingna Xun, Zhenyan Wang, Ling Gu, Qian Li, Dan Yin et al. · 2021 · Clinical & Translational Immunology
72. COVID-19: systemic pathology and its implications for therapy
    Qi Shen, Jie Li, Zhan Zhang, Shuang Guo, Qiuhong Wang, Xiaorui An, Haocai Chang · 2021 · International Journal of Biological Sciences
73. Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
    Ane Ogbe, Matthew J. Pace, Mustapha Bittaye, Timothy Tipoe, Sandra Adele, Jasmini Alagaratnam, Parvinder K. Aley, M. Azim Ansari, Anna Bara, Samantha Broadhead et al. · 2022 · JCI Insight
74. Implicating effector genes at COVID-19 GWAS loci using promoter-focused Capture-C in disease-relevant immune cell types
    Matthew C. Pahl, Carole Le Coz, Chun Su, Prabhat Kumar Sharma, Rajan M. Thomas, James A. Pippin, Emylette Cruz Cabrera, Matthew E. Johnson, Michelle E. Leonard, Sumei Lu et al. · 2022 · Genome biology
75. Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR
    Megan Catherine Schwarz, Denis Torre, Daniel Lozano‐Ojalvo, Anthony Tanoto Tan, Tommaso Tabaglio, Slim Mzoughi, Rodrigo Sánchez-Tarjuelo, Nina Le Bert, Joey Ming Er Lim, Sandra Hatem et al. · 2022 · Nature Biotechnology
76. COVID ‐19 and plasma cells: Is there long‐lived protection?*
    Doan C. Nguyen, Pedro A. Lamothe, Matthew Charles Woodruff, Ankur Singh Saini, Caterina Elisa Faliti, Igñacio Sanz, Frances Eun-Hyung Lee · 2022 · Immunological Reviews
77. A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine
    Sonia Jangra, Jeffrey J. Landers, Raveen Rathnasinghe, Jessica J. O’Konek, Katarzyna W. Janczak, Marília Cascalho, Andrew A. Kennedy, Andrew W. Tai, James R. Baker, Michael Schotsaert et al. · 2021 · Frontiers in Immunology
78. Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
    Manish K. Dhawan, Ali Ahmed Rabaan, Mahmoud M. Fawarah, Souad A. Almuthree, Roua Abdullah Alsubki, Amal H. Alfaraj, Mutaib M. Mashraqi, Saleh Alshamrani, Wesam A. Abduljabbar, Ameen S. S. Alwashmi et al. · 2023 · Vaccines
79. Pathways to Severe COVID‐19 for People with Obesity
    O’Rourke, Robert W., Lumeng, Carey N. · 2021 · Obesity
80. An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination
    Bülent Kantarcıoğlu, Omer Iqbal, Jeanine M. Walenga, Bruce Lewis, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio A. Lievano, Alfonso Javier Tafur, Eduardo Ramacciotti et al. · 2021 · Clinical and Applied Thrombosis/Hemostasis
81. Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity
    I. Abela, C. Pasin, Magdalena Schwarzmüller, Selina Epp, M. Sickmann, M. Schanz, P. Rusert, J. Weber, S. Schmutz, A. Audigé et al. · 2021 · Nature Communications
82. Coronavirus Disease 2019 Outcomes Among Recipients of Anti‐CD20 Monoclonal Antibodies for Immune‐Mediated Diseases: A Comparative Cohort Study
    Naomi J. Patel, Kristin M. D’Silva, Tiffany Y. T. Hsu, Michael A. DiIorio, Xiaoqing Fu, C. Cook, Lauren C. Prisco, Lily K. Martin, Kathleen M.M. Vanni, Alessandra Zaccardelli et al. · 2021 · ACR Open Rheumatology
83. Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens
    Verena Klemis, Tina Schmidt, David Schub, Janine Mihm, Stefanie Marx, Amina Abu‐Omar, Laura Ziegler, Franziska Hielscher, Candida Guckelmus, Rebecca Urschel et al. · 2022 · Nature Communications
84. T cell perturbations persist for at least 6 months following hospitalization for COVID-19
    Melissa Govender, Francis R. Hopkins, Robin Göransson, Cecilia Svanberg, Esaki Muthu Shankar, Maria Hjorth, Åsa Nilsdotter‐Augustinsson, Johanna Sjöwall, Sofia N. Nyström, Marie Larsson · 2022 · Frontiers in Immunology
85. Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs
    Airu Zhu, Zhao Chen, Qihong Yan, Mei Jiang, Xuesong Liu, Zhengtu Li, Na Li, Chunli Tang, Wenhua Jian, Jiangping He et al. · 2025 · Nature Immunology
86. Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain
    Sergi Cantenys-Molina, Eduardo Fernández‐Cruz, P Francos, J. C. Lopez Bernaldo de Quiros, Patricia Muñóz, Juana Gil-Herrera · 2020 · Clinical & Experimental Immunology
87. Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions
    Eric Allan Meyerowitz, Pritha Sen, Sara R. Schoenfeld, Tomas G. Neilan, Matthew J. Frigault, John H. Stone, Arthur Y. Kim, Michael K. Mansour · 2020 · Clinical Infectious Diseases
88. Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses
    Vineet Joag, Sathi Wijeyesinghe, James Michael Stolley, Clare F. Quarnstrom, Thamotharampillai Dileepan, Andrew G. Soerens, Jules A. Sangala, Stephen D. O’Flanagan, Noah Veis Gavil, Sung‐Wook Hong et al. · 2021 · The Journal of Immunology
89. Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients
    Xiuyuan Lu, Yuki Hosono, Masamichi Nagae, Shigenari Ishizuka, Eri Ishikawa, Daisuke Motooka, Yuki Ozaki, Nicolas Sax, Yuichi Maeda, Yasuhiro Kato et al. · 2021 · The Journal of Experimental Medicine
90. Longitudinal Systemic and Mucosal Immune Responses to SARS-CoV-2 Infection
    Peter F. Wright, Alejandra Prevost-Reilly, Harini Natarajan, Elizabeth Bailey Brickley, Ruth I. Connor, Wendy Wieland‐Alter, Anna S Miele, Joshua A. Weiner, Robert D Nerenz, Margaret E. Ackerman · 2022 · The Journal of Infectious Diseases
91. Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model
    John P. Hanley, Huy A. Tu, Julie A. Dragon, Dorothy M. Dickson, Roxana del Río, Scott W. Tighe, Korin M. Eckstrom, Nicholas Selig, Samuel V. Scarpino, Stephen S. Whitehead et al. · 2021 · Nature Communications
92. SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation
    John Tyler Sandberg, Renata Varnaitė, Wanda Christ, Puran Chen, Jagadeeswara Rao Muvva, Kimia T. Maleki, Marina García, Majda Dzidic, Elin Folkesson, Magdalena Skagerberg et al. · 2021 · Clinical & Translational Immunology
93. Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review
    Zhonghao Chen, Ying Zhang, Meng Wang, Md Sahidul Islam, Ping Liao, Yuanjia Hu, Xin Chen · 2022 · International Journal of Biological Sciences
94. Enhanced detection of antigen-specific T cells by a multiplexed AIM assay
    Audrée Lemieux, Gérémy Sannier, Alexandre Nicolas, Manon Nayrac, Gloria-Gabrielle Ortega-Delgado, Rose Cloutier, Nathalie Brassard, Mélanie Laporte, Mélina Duchesne, Alina Maria Sreng Flores et al. · 2024 · Cell Reports Methods
95. Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome
    the RICO study group, Fabienne Venet, Martin Cour, Thomas R. Rimmele, Sébastien Viel, Hodane Yonis, Rémy Coudereau, Camille Amaz, Paul Abraham, Céline Monard et al. · 2021 · Critical Care
96. SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
    Sara Diani, Erika A. Leonardi, Attilio Cavezzi, Simona Ferrari, Oriana Iacono, Alice Limoli, Zoe Bouslenko, Daniele Natalini, Stefania Conti, Mauro Mantovani et al. · 2022 · Journal of Clinical Medicine
97. Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity
    Deanna M. Santer, Daniel Li, Yanal Ghosheh, Muhammad Atif Zahoor, Dhanvi Prajapati, Bettina E. Hansen, D. Lorne Tyrrell, Jordan J. Feld, Adam J. Gehring · 2022 · Nature Communications
98. COVID-19: Relationship and Impact on Breastfeeding—A Systematic Review
    Marcelino Pérez-Bermejo, Belén Peris-Ochando, María Teresa Murillo-Llorente · 2021 · Nutrients
99. Durability of SARS-CoV-2–Specific T-Cell Responses at 12 Months Postinfection
    Zhongyan Lu, Eric D. Laing, Jarina Pena DaMata, Katherine Pohida, Marana S Tso, Emily C Samuels, Nusrat J Epsi, Batsukh Dorjbal, Camille M. Lake, Stephanie A Richard et al. · 2021 · The Journal of Infectious Diseases
100. COVID-19: From emerging variants to vaccination
     Thilini Hemali Senevirathne, Demi Wekking, Joseph W. R. Swain, Cinzia Solinas, Pushpamali De Silva · 2023 · Cytokine & Growth Factor Reviews